R&D channel feed

Tour­ma­line Bio's heart drug cuts in­flam­ma­tion as it seeks to com­pete with No­vo, CSL's as­sets 

Last month

Boehringer In­gel­heim’s late-stage da­ta for lung dis­ease can­di­date un­der­whelm some an­a­lysts

Last month

Prime Med­i­cine side­lines on­ly clin­i­cal pro­gram, re­places CEO and lays off some staff

Last month
People
Cell/Gene Tx

In­tel­li­a's CRISPR ther­a­py like­ly caus­es 'per­ma­nen­t' gene knock­down in AT­TR amy­loi­do­sis

Last month
Pharma
Cell/Gene Tx

David Liu, Sam Stern­berg un­veil new way to in­sert big genes in hu­man cells

Last month
Cell/Gene Tx

Ap­n­imed posts first set of Phase 3 sleep ap­nea re­sults, aims for ap­proval fil­ing in 2026

Last month
Startups

Sarep­ta seeks to ex­pand Duchenne gene ther­a­py Ele­v­idys use to tod­dlers

Last month
FDA+

Low­er at­ten­dance at cell and gene ther­a­py con­fer­ence mir­rors chal­lenged in­dus­try

Last month
Cell/Gene Tx

In three pa­tients, Rock­et’s sec­ond heart gene ther­a­py shows promise

Last month
Cell/Gene Tx

RFK Jr. adopts new chikun­gun­ya vac­cine guid­ance; oth­er rec­om­men­da­tions re­main un­der re­view

Last month
Pharma
FDA+

The in­side sto­ry of the six-month sprint to cre­ate the first cus­tom CRISPR ther­a­py for one in­fant’s rare dis­ease

Last month
Cell/Gene Tx
In Focus

Ad­vo­ca­cy groups and ex­perts call for decade-long ban on germline edit­ing

Last month
Cell/Gene Tx

Arc­turus to pri­or­i­tize mR­NA ther­a­peu­tics in bid to boost rare dis­ease pro­grams

Last month

Cy­to­ki­net­ics gets an 'in­cre­men­tal' win for de­layed heart drug

Last month

TIG­IT grave­yard ex­pands as GSK drops late-stage as­set with iTeos

Last month

Vir’s hep B dis­ap­point­ment, Ipsen's new Iqir­vo da­ta, plus more from #EASL25

Last month

Lil­ly says fur­ther head-to-head tri­al da­ta back Zep­bound over No­vo’s We­govy

Last month

Trump says he'll sign or­der on 'most fa­vored na­tion' drug price plans Mon­day

Last month
Pharma

Rev­o­lu­tion’s KRAS drugs ap­pear com­pet­i­tive in sev­er­al lung can­cer set­tings

2 months ago

Corvus' ear­ly-phase atopic der­mati­tis da­ta prompt stock ral­ly

2 months ago

'Find a way, or make one': How two sci­en­tists hope to re­vi­tal­ize CRISPR's rare dis­ease cri­sis

2 months ago
Cell/Gene Tx
In Focus

Lan­theus culls late-stage Lil­ly-part­nered prostate can­cer ra­di­oli­gand

2 months ago

Gilead re­veals plans to put an­oth­er $11B in­to US man­u­fac­tur­ing

2 months ago
Pharma
Manufacturing

Theri­va’s on­colyt­ic virus suc­ceeds in pan­cre­at­ic can­cer study, but stock falls

2 months ago
First page Previous page 45678910 Next page Last page
A service from the Financial Times